ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma
Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. American Journal Of Clinical Oncology 2015, 38: 610-620. PMID: 26583344, DOI: 10.1097/coc.0000000000000215.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsBleomycinCyclophosphamideDoxorubicinEtoposideHumansLymphoma, Large B-Cell, DiffuseMediastinal NeoplasmsPrednisoneRadiotherapyRituximabVincristineVindesineConceptsDiffuse large B-cell lymphomaLarge B-cell lymphomaB-cell lymphomaAppropriateness CriteriaRole of radiationPositron emission tomography/Ann Arbor stagingAppropriateness of imagingDifferent chemotherapy regimensACR Appropriateness CriteriaRecent prospective studiesInternational Prognostic IndexRadiology Appropriateness CriteriaMultidisciplinary expert panelEvidence-based guidelinesEmission tomography/Specific clinical conditionsCurrent medical literatureChemotherapy regimensPeer-reviewed journalsInitial diagnosisPrognostic indexProspective studyRetrospective studyTomography/